Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.

Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.

<h4>Background</h4>Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect profile compared to routinely...

Full description

Bibliographic Details
Main Authors: Saskia van Henten, Annisa Befekadu Tesfaye, Seid Getahun Abdela, Feleke Tilahun, Helina Fikre, Jozefien Buyze, Mekibib Kassa, Lieselotte Cnops, Myrthe Pareyn, Rezika Mohammed, Florian Vogt, Ermias Diro, Johan van Griensven
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009460&type=printable

Internet

https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009460&type=printable

Similar Items